All News

2058 articles, sorted by publication time.

Vaccines and Infectious Diseases · africa

DRC launches Bundibugyo virus vaccine trial, first testing whether Ervebo can provide cross-virus protection

With no vaccine yet approved against Bundibugyo virus, the Tumaini trial has begun vaccinations and is preparing to include new candidates designed specifically for the virus. Key questions are whether an existing Ebola vaccine’s protection can extend to this virus and how to build reliable evidence for high-risk groups during an outbreak.

Cancer and Precision Medicine · global

Divarasib prolongs survival in Phase 3 lung cancer trial, outperforming existing KRAS G12C targeted drugs

Among 338 previously treated patients with advanced lung cancer, median overall survival reached 17.7 months with divarasib, compared with 12 months in the control group. The study, which directly compared divarasib with existing targeted drugs, also showed fewer severe treatment-related side effects, although the findings have limits to their applicability.

Cancer Care · global

Personalized mRNA Cancer Vaccine Meets Phase 3 Endpoints, Adding Evidence for Postsurgical Melanoma Treatment

Intismeran, tailored to mutations in each patient’s tumor, improved recurrence-free and distant metastasis-free survival when combined with immunotherapy in a large trial. This provides new evidence for reducing recurrence risk after surgery, but the August announcement did not disclose the magnitude of benefit, and overall survival remains under follow-up.